A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies.
about
A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A novel ruthenium (II)-derived ...... : Ex vivo and in vivo studies.
@en
type
label
A novel ruthenium (II)-derived ...... : Ex vivo and in vivo studies.
@en
prefLabel
A novel ruthenium (II)-derived ...... : Ex vivo and in vivo studies.
@en
P2093
P2860
P1433
P1476
A novel ruthenium (II)-derived ...... : Ex vivo and in vivo studies.
@en
P2093
Chao-Chien Chang
Chih-Hsuan Hsia
Joen-Rong Sheu
Kuan-Hung Lin
Marappan Velusamy
Thanasekaran Jayakumar
Themmila Khamrang
Wan-Jung Lu
P2860
P2888
P356
10.1038/S41598-017-09695-Z
P407
P577
2017-08-25T00:00:00Z